Contravisory Investment Management, Inc. Adma Biologics, Inc. Transaction History
Contravisory Investment Management, Inc.
- $450 Million
- Q1 2025
A detailed history of Contravisory Investment Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 10,757 shares of ADMA stock, worth $218,797. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,757
Previous 10,811
0.5%
Holding current value
$218,797
Previous $185,000
17.3%
% of portfolio
0.05%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$379 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$343 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$262 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$233 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$115 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.99B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...